Origenis
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Am Klopferspitz 19a, Planegg, Bavaria, 8...Phone Number
+49 8978016760Website
www.origenis.deRevenue
$7.4 MillionIndustry
ZI Rank: 1
About Origenis
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Origenis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Origenis, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Origenis launches new products
Earning: See what the market has to say on Origenis recently announced quarterly report
Funding: Get notified immidiatlly once Origenis has new funding data
Congratulate Masked Content for being promoted to Masked Content at Origenis
Check if Origenis has recently received funding, and reach out quickly before it becomes old news!
Check out if Origenis is spiking on competitors!
Click to see if Origenis had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Origenis
Find 2 more new buyers
Company Profile Activity
Activity Insights
Origenis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Origenis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Origenis.
Origenis Tech Stack
A closer look at the technologies used by Origenis
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Origenis
Origenis GmbH specializes in curing diseases through the development of novel small molecule drugs, particularly in areas where no existing treatments have been discovered. The company utilizes an AI-driven technology platform to create synergistic drug pipelines that focus on highly selective protein kinase and protease inhibitors. Their innovativ... Read More
